Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Controlled Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
This study is currently recruiting participants.
Study NCT00606580 Information provided by U.S. Army Medical Research and Materiel Command
First Received: January 21, 2008 Last Updated: January 5, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cutaneous Leishmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Cutaneous
More general conditions related to this trial
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
WR 279,396 topical cream
Paromomycin topical cream
Topical cream placebo
Additional drug interventions recognized in this trial
Paromomycin
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
U.S. Army Medical Research and Materiel Command
Walter Reed Army Institute of Research (WRAIR)
Back to top of Main Content
